Mannix Aklian serves as Chief Commercial Officer and Global Head of Software Sales & Marketing at Schrödinger Inc., where he drives the company's global commercial strategy for its transformative computational platform. In this pivotal role, Aklian oversees sales, marketing, and business development across software solutions that empower pharmaceutical, biotechnology, and materials science industries to accelerate drug discovery and molecular design. His leadership has been instrumental in expanding Schrödinger's market presence, forging strategic partnerships with top-tier biopharma leaders, and scaling revenue through innovative go-to-market initiatives tailored to the evolving needs of computational chemistry users. With more than 20 years of experience in high-tech sales and marketing within the life sciences sector, Aklian has built a distinguished career marked by consistent revenue growth and market expansion. Prior to joining Schrödinger, he held senior executive positions at leading software firms, including Vice President of Global Sales at a prominent molecular modeling company and key roles at enterprise SaaS providers focused on scientific computing. Under his guidance, previous organizations achieved double-digit year-over-year growth, launched award-winning product suites, and penetrated new geographies, earning him recognition as a top sales leader in the industry. Aklian's achievements include spearheading multimillion-dollar deals with Fortune 500 clients, optimizing sales operations through data-driven strategies, and fostering a customer-centric culture that has propelled Schrödinger's software business to record highs. A graduate of the University of California, Berkeley with a degree in Business Administration and advanced training in computational biology, he combines deep domain expertise with a proven track record of commercial excellence, positioning Schrödinger at the forefront of the digital transformation in drug discovery.